Genentech Alteplase In Line For August Action On Catheter Clearance sBLA
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Genentech’s Activase (alteplase) sBLA for unclogging central venous access catheters (CVAC) is based on study results showing a 74% rate of clearance following the first dose of the recombinant tissue plasminogen activator (t-PA).